Business Standard

Monday, December 23, 2024 | 12:45 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Torrent Pharma posts Q4FY20 PBT of Rs 293 cr, consolidated revenue up 4.69%

The company saw its total consolidated revenue in Q4FY20 at Rs 1961 crore, up by a marginal 4.69 per cent over Rs 1873 crore in Q4FY19

pharma, medicines, drugs
Premium

Brazil market saw constant currency sales grow by 11 per cent to R$119 million, driven by new launches and market share gain

Vinay Umarji Ahmedabad
On the back of the synergies of the acquired Unichem portfolio, drug maker Torrent Pharmaceuticals Ltd posted a consolidated profit before tax (PBT) of Rs 293 crore for the quarter ended March 30, 2020. In Q4FY19, the company had posted a consolidated loss before tax of Rs 150 crore.

The company saw its total consolidated revenue in Q4FY20 at Rs 1961 crore, up by a marginal 4.69 per cent over Rs 1873 crore in Q4FY19. For the full financial year, while Torrent Pharma posted an over 110 per cent growth in its consolidated PBT at Rs 1187 crore in FY20, up

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in